Clinical Trials Browser

Interventional × Anophthalmia with pulmonary hypoplasia × Gastrointestinal × Clear all

NCT05005403 2026-05-13

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

BreastGastrointestinalHead & NeckThoracic

Anophthalmia with pulmonary hypoplasia, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

NCT05475366 2026-05-01

PACsign

Phase NA Recruiting

85 enrolled

Gastrointestinal

Anophthalmia with pulmonary hypoplasia, Carcinoma, Pancreatic Ductal

NCT06361030 2024-04-11

Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer

Phase 2 Not yet recruiting

40 enrolled

Gastrointestinal

Anophthalmia with pulmonary hypoplasia, Pancreatic Neoplasms

NCT02132403 2015-05-01

PM-01

Phase 1 Terminated

3 enrolled

Gastrointestinal

Anophthalmia with pulmonary hypoplasia, Neoplasm Metastasis, Pancreatic Neoplasms, Recurrence